european patent, page-23

Surges, I find the mention of Serotonin interesting.

A couple of years ago, I was looking at possible links between OBJ and Solvay. It was based on research into transdermanl delivery of SSRI's, namely Fluvoxamine.
In 2009, when Solvay Pharma was sold to Abbott in 09 or so, I lost track of where the research was going.
A link with OBJ in this area would be very lucrative given the increasing focus globally on delivering and monitoring effective doses of SSRI's